Compliance and Regulatory Updates

FDA Regulatory Update – What Makary’s “New FDA” Means for the Life Sciences Industry

FDA’s Vision for Transparency and Accountability The latest FDA regulatory update is drawing attention across the life sciences and government contracting world. Dr. Marty Makary’s vision of a “New FDA” centers on increasing transparency, streamlining the approval process, and promoting stronger accountability in how medical products reach the market. For contractors tied to federal health…

Decoding the Federal Procurement Process

Decoding the Federal Procurement Process: Timelines, Players, and Hidden Rules

The federal procurement process often feels like a mystery filled with endless timelines, multiple players, and hidden rules. This post breaks it down into manageable steps, explaining how to navigate “hurry up and wait” timelines, understand the roles of contracting officers, program managers, and evaluators, and uncover the unwritten rules that really drive success. With…

GSK $30 Billion U.S. Investment in Pharma

GSK $30 Billion U.S. Investment in Pharma

The news of GSK’s $30 billion U.S. investment is making waves across the pharmaceutical and manufacturing world. Over the next five years, the company plans to strengthen its research and development presence while expanding critical manufacturing facilities. This massive commitment includes a new $1.2 billion facility in Pennsylvania dedicated to respiratory and cancer treatments, along…